Looking forward, new guidelines from the 2024 IGCLC consensus conference in Porto are expected to refine genetic screening and risk management strategies for LBC associated with CDH1 variants. Here, CDH1 is linked to CDH1-related diffuse gastric and lobular breast cancer syndrome.